View Cart (0 items)

Pharmaceutical

BASF to sell part of API business

BASF has announced plans to sell parts of its pharmaceuticals business and three manufacturing plants for EUR270 million ($301 million) in order to focus on its core expertise in pharmaceutical excipients.
Read More